Welcome to the 2nd HBA-USA Conference
New York, NY - October 15-16
Moving from basic to translational research via novel technologies
Columbia University, Amsterdam Ave & 116th st, New York, NY
Schermerhorn Building, Rm 501, Columbia University
Final Program
Saturday, October 15
2pm - Registration
3pm
Opening Remarks :
Thomas Thomou, PhD, President of the HBA-USA
Thomas Nikolakakis, Board member of Columbia University Hellenic Association
Aghie Balta, Consul General of Greece in New York
Koula Sophianou, Consul General of Cyprus in New York
Nomination of HBA-USA Honorary Members
Dr. Stavros Vougiouklakis
Mrs. Niki Sideris
Presentation of the Award for Outstanding Contribution in Bioscience Education
Prof. Vassilis I. Zannis , Boston Univ. and Univ. of Crete
Award presentation by Dr. Konstantinos Drosatos, Columbia and World Hellenic Biomedical Association
Presentation of the 2nd "Aristoteles Award" for Outstanding Achievements in Biosciences
Prof. Charalambos Gavras , Boston University
Award Presentation by Prof. Litsa Kranias, Univ. of Cincinatti
Keynote Presentation
The Renin-Angiotensin system, past and present
5 - 7pm - Presentations by members with outstanding publications
Iannis Aifantis , PhD
Associate Professor, New York University & Howard Hughes Medical Institute
Epigenetic regulation of stem cell differentiation and transformation
Charalampos Kalodimos , PhD
Associate Professor, Rutgers University
Dynamic activation of an allosteric regulatory protein
Poulikos Poulikakos , PhD
Research Associate, Memorial Sloan Kattering
RAF inhibitors trans-activate RAF dimers and ERK signaling in cells with wild type BRAF
Nick Vlahakis , MD
Associate Professor of Medicine, Mayo Clinic
Thrombosis in the ICU: Mechanisms and prophylaxis
8 - 10pm - Reception
Reception will take place at 4 Points by Sheraton Hotel, 27-05 39th Avenue, Long Island City, NY 11101 - (718) 786-8500
Sunday, October 16
Session 1: Novel technologies and applications
Coordinatos : Emmanouela Filippidi, NYU and Ioannis Zervantonakis, MIT
9.45-10.015
The Christos S. Polentas Distinguished lecture by
Nikos Kyrpides, PhD
Head of the DOE Genome Biology Program
Department of Energy Joint Genome Institute, Walnut Creek, CA
The future of Microbial Genomics
10.15-10.35
Nikos Chronis, PhD
Assistant Professor, Mechanical Engineering, Univ. of Michigan
Enabling Translational Research though Bio-MicroElectroMechanical Systems (bioMEMS)
10.35-10.55
Maria P. Limberis, PhD
Research Assistant Professor of Pathology and Laboratory Medicine
University of Pennsylvania, Philadelphia PA
Virus vector-mediated antibody expression in vivo to prevent pandemic flu
Session 2: Metabolism and cardiovascular biology
Coordinators : Iordanes Karagiannides, PhD, UCLA and Konstantinos Drosatos, Columbia Univ.
11.15-11.45
The Atlantic Bank of New York Distinguished lecture by
Litsa Kranias, PhD
Distinguished University Professor - University of Cincinnati College of Medicine
Calcium Circuits in Heart Failure
11.45-12.10
George Tellides, MD, PhD
Professor of Surgery, Cardiothoracic and Investigative Medicine
Yale University, School of Medicine, New Haven, CT
Chief of Cardiothoracic Surgery
Immune-mediated Vascular Remodeling
12.10-12.35
Chris J. Vlahos, PhD
Manager, Global External R&D - Lilly Research Laboratories, Indianapolis, IN
Cardiocascular Drug Development: Challenges and Promises
12.35-12.55
Anastasios Lymperopoulos, PhD
Assistant Professor of Pharmaceutical Sciences, College of Pharmacy
Nova Southeastern University , Fort Lauderdale, FL
A new therapeutic target in heart failure: adrenal β arrestin-1 and aldosterone regulation
Lunch Break
Session 3: Cancer and Immunology
Coordinator : Athanasios Vassilopoulos, PhD, Vanderbilt University
2.00-2.30
The Pangregorian Enterprizes of Metro NY and LI Distinguished lecture by
John M. Kyriakis, PhD
Professor of Medicine - Tufts University School of Medicine
Novel functions for the Mst2 tumor suppressor
2.30-2.55
Constantine A.Stratakis, MD, DSc
Director & Chief, Section of Endocrinology & Genetics
DEB & Heritable Disorders Branch, National Institute of Child Health and Human Development
cAMP signaling defects and tumors
2.55-3.20
Gabriela Chiosis, Ph.D.
Principal Investigato, Molecular Pharmacology and Chemistry - Memorial Sloan-Kettering Cancer Center
The Hsp90 Inhibitor PU-H71: from bench to bedsize
3.20-3.40
Dimitrios Iliopoulos, PhD
Assistant Professor of Pathology, Harvard Medical School & Dana Farber Cancer Institute
Identification of selective inhibitors of colon cancer stem cells through high throughput screening
Session 4: Collaborations in Life Sciences Education and Research in the United States and Greece
4.00-4.15
Thomas Thomou, PhD
HBA-USA President and Research Fellow, Harvard Medical School
Science Teaching Exchange Program between HBA-USA and Univ. of Thessaloniki & Ioannina
4.15-4.30
Vassilis I. Zannis, PhD
Professor & Director of the Division of Molecular Genetics, Boston University School of Medicine
Boston University School of Medicine & University of Crete Exchange Program
4.30-4.45
John S. Evans, D.Sc.
Professor, Environmental Sciences, Harvard School of Public Health
Co-Director, Harvard Cyprus Program
Harvard University & Univ. of Cyprus Institute Program
4.45-5.00
Leon Stavrou
Executive Director, The Next Generation Initiative
Working with American Students and Professors: The Next Generation Experience
5.00-6.00
Panel Discussion
above speaker and
Stelios Papadopoulos, PhD
BG-Medicine & Fondation Sante, a non-profit organisation aiming to foster multidisciplinary collaborative and educational efforts
6.15
Closing Remarks / Open discussion
